Acute Leukemias II

Prognostic Factors and Treatment Strategies

  • T. Büchner
  • G. Schellong
  • W. Hiddemann
  • J. Ritter
Conference proceedings

Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 33)

Table of contents

  1. Front Matter
    Pages I-XXXI
  2. Leukemia Cell Biology and Basic Science

    1. Front Matter
      Pages 1-1
    2. C. R. Bartram, J. W. G. Janssen
      Pages 17-22
    3. A. Hagemeijer, D. C. van der Plas
      Pages 23-30
    4. S. Slavin, A. Eckerstein, I. Hardan, M. Ben Shahar, R. Or, E. Naparstek et al.
      Pages 36-40
    5. H. J. Adriaansen, H. Hooijkaas, M. C. Kappers-Klunne, K. Hählen, M. B. van’t Veer, J. J. M. van Dongen
      Pages 41-49
    6. M. Volkmann, P. Mar, K. Pachmann, E. Thiel, B. Emmerich
      Pages 50-55
    7. I. Doxiadis, P. Dölken, M. E. Schneider, P. Wernet, H. Grosse-Wilde
      Pages 62-66
    8. W. Siegert, O. Josimovic-Alasevic, R. Schwerdtfeger, C. Schmidt, A. Neubauer, G. Henze et al.
      Pages 76-77
    9. D. Douer, I. Ben-Bassat, A. Kneller, S. D. Chitayat, N. Shaked, S. Salzberg et al.
      Pages 78-82
    10. W. Jelkmann, H. Johannsen, G. Wiedemann, M. Otte, T. Wagner
      Pages 83-86
    11. K. H. Pflüger, A. Grüber, M. Welslau, H. Köppler, K. Havemann
      Pages 87-94
    12. C. Schrader, M. Reuter, K. Mempel, W.-D. Ludwig, H. Riehm, G. Schellong et al.
      Pages 95-97

About these proceedings

Introduction

Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero­ unsatisfactory cure rates even in special sub­ geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa­ effective supportive care show some increase tients other cases prove to be highly resis­ in the initial response rates and certain im­ tant. The curability is superior in acute provements in the long-term results, no ben­ lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.

Keywords

Akute Leukämie Knochenmarktransplantation adoptive Immuntherapie classification hämatopoetische Wachstumsfaktoren imaging morbidity

Editors and affiliations

  • T. Büchner
    • 1
  • G. Schellong
    • 1
  • W. Hiddemann
    • 1
  • J. Ritter
    • 1
  1. 1.Departments of Internal Medicine and PediatricsUniversity of MünsterMünsterFederal Republic of Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-74643-7
  • Copyright Information Springer-Verlag Berlin Heidelberg 1990
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-50984-4
  • Online ISBN 978-3-642-74643-7
  • Series Print ISSN 0440-0607
  • About this book